Auriga Maintains a 'Hold' on Myriad Genetics (MYGN); Q4 Results Review: A Good Performance; Ramping Investment in FY12
Go back to Auriga Maintains a 'Hold' on Myriad Genetics (MYGN); Q4 Results Review: A Good Performance; Ramping Investment in FY12| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.03 -0.14 (4.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.17 | 52 Week High | $45.34 | |||
| Open | $3.17 | 52 Week Low | $15.92 | |||
| Day High | $3.18 | P/E | 1.30 | |||
| Day Low | $3.01 | EPS | $2.33 | |||
| Volume | 1,555,166 | |||||
